199 related articles for article (PubMed ID: 3142346)
1. Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia.
Clarkson AB; Williams DE; Rosenberg C
Antimicrob Agents Chemother; 1988 Aug; 32(8):1158-63. PubMed ID: 3142346
[TBL] [Abstract][Full Text] [Related]
2. Deferoxamine and eflornithine (DL-alpha-difluoromethylornithine) in a rat model of Pneumocystis carinii pneumonia.
Clarkson AB; Sarić M; Grady RW
Antimicrob Agents Chemother; 1990 Sep; 34(9):1833-5. PubMed ID: 2285303
[TBL] [Abstract][Full Text] [Related]
3. Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.
Hughes WT
Antimicrob Agents Chemother; 1988 May; 32(5):623-5. PubMed ID: 3260765
[TBL] [Abstract][Full Text] [Related]
4. Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Fischl MA
AIDS; 1988; 2 Suppl 1():S143-50. PubMed ID: 2976274
[No Abstract] [Full Text] [Related]
5. Pneumocystis carinii pneumonia in the patient with AIDS.
Catterall JR; Potasman I; Remington JS
Chest; 1985 Nov; 88(5):758-62. PubMed ID: 3931990
[No Abstract] [Full Text] [Related]
6. Effect of folinic acid on the capacity of trimethoprim-sulfamethoxazole to prevent and treat Pneumocystis carinii pneumonia in rats.
D'Antonio RG; Johnson DB; Winn RE; van Dellen AF; Evans ME
Antimicrob Agents Chemother; 1986 Feb; 29(2):327-9. PubMed ID: 3487285
[TBL] [Abstract][Full Text] [Related]
7. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
Medina I; Mills J; Leoung G; Hopewell PC; Lee B; Modin G; Benowitz N; Wofsy CB
N Engl J Med; 1990 Sep; 323(12):776-82. PubMed ID: 2392131
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of CNS-trypanosomiasis: the combined use of diminazene aceturate or pentamidine with DL-alpha-difluoromethylornithine (DFMO).
Jennings FW
Trop Med Parasitol; 1992 Jun; 43(2):106-9. PubMed ID: 1519020
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
10. Pentamidine aerosol in prophylaxis and treatment of murine Pneumocystis carinii pneumonia.
Girard PM; Brun-Pascaud M; Farinotti R; Tamisier L; Kernbaum S
Antimicrob Agents Chemother; 1987 Jul; 31(7):978-81. PubMed ID: 3499116
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment and prevention of murine Pneumocystis carinii pneumonitis with 4,4'-sulfonylbisformanilide.
Hughes WT; Smith BL; Jacobus DP
Antimicrob Agents Chemother; 1986 Mar; 29(3):509-10. PubMed ID: 3487287
[TBL] [Abstract][Full Text] [Related]
12. Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia.
Walzer PD; Kim CK; Foy J; Linke MJ; Cushion MT
Antimicrob Agents Chemother; 1988 Jun; 32(6):896-905. PubMed ID: 3137861
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy of drug-resistant Trypanosoma brucei rhodesiense infections in mice using DL-alpha-difluoromethylornithine and standard trypanocides.
Bacchi CJ; Nathan HC; Yarlett N; Goldberg B; McCann PP; Sjoerdsma A; Saric M; Clarkson AB
Antimicrob Agents Chemother; 1994 Mar; 38(3):563-9. PubMed ID: 8203855
[TBL] [Abstract][Full Text] [Related]
14. Combination of pentamidine and trimethoprim-sulfamethoxazole in therapy of Pneumocystis carinii pneumonia in rats.
Kluge RM; Spaulding DM; Spain AJ
Antimicrob Agents Chemother; 1978 Jun; 13(6):975-8. PubMed ID: 307941
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study.
Sattler FR; Cowan R; Nielsen DM; Ruskin J
Ann Intern Med; 1988 Aug; 109(4):280-7. PubMed ID: 3260759
[TBL] [Abstract][Full Text] [Related]
16. Continuous infusion of DL-alpha-difluoromethylornithine and improved efficacy against a rat model of Pneumocystis carinii pneumonia.
Chin K; Merali S; Sarić M; Clarkson AB
Antimicrob Agents Chemother; 1996 Oct; 40(10):2318-20. PubMed ID: 8891137
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
Bucher HC; Griffith L; Guyatt GH; Opravil M
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):104-14. PubMed ID: 9241108
[TBL] [Abstract][Full Text] [Related]
18. Pneumocystis carinii pneumonia treated with eflornithine in AIDS patients resistant to conventional therapy.
Smith D; Davies S; Nelson M; Youle M; Gleeson J; Gazzard B
AIDS; 1990 Oct; 4(10):1019-21. PubMed ID: 2261116
[TBL] [Abstract][Full Text] [Related]
19. Failure of trimethoprim-sulfamethoxazole in the therapy of recurrent Pneumocystis carinii pneumonia.
Mitsuyasu RT; Corwin HL; Harris AA; Trenholme GM; Levi S; Karkusis PH
Am Rev Respir Dis; 1982 Jun; 125(6):762-5. PubMed ID: 6979960
[TBL] [Abstract][Full Text] [Related]
20. Pneumocystis carinii pneumonia treated with alpha-difluoromethylornithine. A prospective study among patients with the acquired immunodeficiency syndrome.
Golden JA; Sjoerdsma A; Santi DV
West J Med; 1984 Nov; 141(5):613-23. PubMed ID: 6440364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
